← Back
$CVKD All transactions

Cadrenal Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$16K

Shares

1,129

Price

$14

Filed

Oct 28

Insider

Name

Pham Quang X

Title

CEO and Chairman

CIK

0001405290

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-10-24

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

197,404

Footnotes

Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.10. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.00. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.

Filing Info

Accession No.

0001213900-25-103146

Form Type

4

Issuer CIK

0001937993

Pham Quang X's History

Date Ticker Type Value
2025-10-27 CVKD $18K
2025-10-24 CVKD $16K
2025-10-13 CVKD $25K
2025-10-09 CVKD $25K
2025-10-02 CVKD $7K
2025-10-01 CVKD $12K
2025-09-29 CVKD $6K
2025-09-25 CVKD $96K
2025-09-24 CVKD $36K
2025-08-28 CVKD $17K

Other Insiders at CVKD (90d)

No other insider activity at this issuer in the last 90 days.